IMU 1.79% 5.5¢ imugene limited

"EnGeneIC is a clinical stage biopharmaceutical company focused...

  1. 46 Posts.
    lightbulb Created with Sketch. 28
    "EnGeneIC is a clinical stage biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of chemotherapeutics and functional nucleic acids in cancer. The EDV™ is a first-in-class Cyto-Immunotherapy platform that enables current cancer treatments to be more potent and far less toxic, while also stimulating a potent anti-tumor immune response."

    Doesn't sound "paradigm shifting" to me.... just another delivery method for the same old toxic cancer drugs....

    Happy to be enlightened????

    At any rate I have emmence confidence in our board and science.

    The only real loser here will be cancer, and winners the cancer sufferers.
 
watchlist Created with Sketch. Add IMU (ASX) to my watchlist
(20min delay)
Last
5.5¢
Change
-0.001(1.79%)
Mkt cap ! $404.2M
Open High Low Value Volume
5.5¢ 5.6¢ 5.4¢ $757.1K 13.81M

Buyers (Bids)

No. Vol. Price($)
16 2203877 5.4¢
 

Sellers (Offers)

Price($) Vol. No.
5.5¢ 244428 4
View Market Depth
Last trade - 16.10pm 25/07/2024 (20 minute delay) ?
IMU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.